Literature DB >> 15774610

Serial changes in plasma brain natriuretic peptide concentration at the infarct and non-infarct sites in patients with left ventricular remodelling after myocardial infarction.

A Hirayama1, H Kusuoka, H Yamamoto, Y Sakata, M Asakura, Y Higuchi, H Mizuno, K Kashiwase, Y Ueda, Y Okuyama, M Hori, K Kodama.   

Abstract

OBJECTIVES: To clarify the role of infarct and non-infarct sites on left ventricular (LV) remodelling after myocardial infarction by measuring brain natriuretic peptide (BNP) from each site. METHODS AND
RESULTS: BNP from the aorta and the anterior interventricular vein (AIV) was measured in 45 patients with first anterior myocardial infarction at one, six, and 18 months. The LV was significantly dilated (> 10 ml/m(2) of end diastolic volume from one to 18 months) in 20 patients (remodelling (R) group) but not in 25 others (non-remodelling (NR) group). Patient characteristics and LV functions did not differ significantly at one month but plasma BNP concentration was higher in group R than in group NR (336 (288) v 116 (106) pg/ml, p < 0.01), predicting the degree of LV dilatation. The difference in BNP concentration between the aortic root and AIV (DeltaBNP), reflecting BNP secreted from the infarct site, did not differ at one month. In both groups BNP and DeltaBNP significantly decreased from one to six months (p < 0.05) and decreased from six months to 18 months, but the change was not significant. BNP and DeltaBNP were significantly higher in group R than in group NR after six months, when LV dilatation was not evident in both groups.
CONCLUSION: Enhanced BNP secretion at one month in the non-infarct and infarct ventricular sites predicts subsequent LV dilatation (that is, remodelling). The slower process of LV remodelling decreased BNP secretion at both sites. Thus, BNP concentration should be useful for monitoring ventricular remodelling after infarction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774610      PMCID: PMC1769221          DOI: 10.1136/hrt.2004.049635

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  21 in total

1.  Advantages and applications of the centerline method for characterizing regional ventricular function.

Authors:  F H Sheehan; E L Bolson; H T Dodge; D G Mathey; J Schofer; H W Woo
Journal:  Circulation       Date:  1986-08       Impact factor: 29.690

2.  Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.

Authors:  H D White; D B Cross; J M Elliott; R M Norris; T W Yee
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

3.  Appearance of atrial natriuretic peptide in the ventricles in patients with myocardial infarction.

Authors:  M Jougasaki; H Yasue; M Mukoyama; K Nakao; K Takahashi
Journal:  Am Heart J       Date:  1990-01       Impact factor: 4.749

4.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

5.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

6.  Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size.

Authors:  A Hirayama; T Adachi; S Asada; M Mishima; S Nanto; H Kusuoka; K Yamamoto; Y Matsumura; M Hori; M Inoue
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

7.  Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Authors:  H Yasue; M Yoshimura; H Sumida; K Kikuta; K Kugiyama; M Jougasaki; H Ogawa; K Okumura; M Mukoyama; K Nakao
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

8.  Cardiac hypertrophy: useful adaptation or pathologic process?

Authors:  W Grossman
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

Review 9.  Ventricular enlargement and reduced survival after myocardial infarction.

Authors:  M A Pfeffer; J M Pfeffer
Journal:  Circulation       Date:  1987-05       Impact factor: 29.690

10.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.

Authors:  R G McKay; M A Pfeffer; R C Pasternak; J E Markis; P C Come; S Nakao; J D Alderman; J J Ferguson; R D Safian; W Grossman
Journal:  Circulation       Date:  1986-10       Impact factor: 29.690

View more
  9 in total

Review 1.  Natriuretic peptides in heart failure: where we are, where we are going.

Authors:  Alberto Palazzuoli; Giovanni Antonelli; Ilaria Quatrini; Ranuccio Nuti
Journal:  Intern Emerg Med       Date:  2010-09-18       Impact factor: 3.397

Review 2.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

3.  Paradoxical relationship between B-type natriuretic peptide and pulmonary vascular resistance in patients with ventricular septal defect and concomitant severe pulmonary hypertension.

Authors:  Manatomo Toyono; Kenji Harada; Masamichi Tamura; Mieko Aoki-Okazaki; Shunsuke Shimada; Jun Oyamada; Goro Takada
Journal:  Pediatr Cardiol       Date:  2007-09-05       Impact factor: 1.655

Review 4.  Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.

Authors:  Albert Busch; Suzanne M Eken; Lars Maegdefessel
Journal:  Ann Transl Med       Date:  2016-06

5.  Physiology and clinical significance of natriuretic hormones.

Authors:  Sandeep Chopra; Davis Cherian; Prashant Paul Verghese; Jubbin J Jacob
Journal:  Indian J Endocrinol Metab       Date:  2013-01

6.  The optimal time of B-type natriuretic peptide sampling associated with post-myocardial infarction remodelling after primary percutaneous coronary intervention.

Authors:  Hyunmin Choi; Byung-Su Yoo; Joon-Hyung Doh; Hee-Jeong Yooh; Min-Soo Ahn; Jang-Young Kim; Seung-Hwan Lee; Junghan Yoon
Journal:  Cardiovasc J Afr       Date:  2013-06       Impact factor: 1.167

7.  A comparative study of time-specific oxidative stress after acute myocardial infarction in patients with and without diabetes mellitus.

Authors:  Daisuke Kitano; Tadateru Takayama; Koichi Nagashima; Masafumi Akabane; Kimie Okubo; Takafumi Hiro; Atsushi Hirayama
Journal:  BMC Cardiovasc Disord       Date:  2016-05-23       Impact factor: 2.298

8.  Dynamic fluctuations of advanced glycation end products and its C-terminal truncated receptor level in patients with acute ST-segment elevation myocardial infarction and undergoing diabetes or not: A retrospective study.

Authors:  Hui Qiu; Wei-Ping Li; Xu-Hua Shen; Xiang-Yu Guo; Bing Hua; Hong-Wei Li
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Serial Changes in Exercise Capacity, NT-proBNP, and Adiponectin in Patients with Acute Coronary Syndrome before and after Phase II Rehabilitation as well as at the 12-Month Follow-Up.

Authors:  Hong Jin; Yuefei Liu; Bernd Schweikert; Harry Hahman; Lei Wang; Armin Imhof; Rainer Muche; Wolfgang König; Jürgen M Steinacker
Journal:  Cardiol Res Pract       Date:  2022-01-24       Impact factor: 1.866

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.